However, clinical studies have demonstrated preliminary associations between adiponectin and obesity-related cardiac dysfunction and MMVD, and adiponectin is promising as a biomarker for metabolic health and age-associated disease in dogs (123, 124). Here, ADIPOQ is linked to obesity due to melanocortin 4 receptor deficiency.